High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients

Infection

Volumn 24, Issue 3, 1996, Pages 213-217

  Hober, D ^a   Benyoucef, S ^a   Delannoy, A S ^a   De Groote, D ^b   Ajana, F ^c   Mouton, Y ^c   Wattre P ^a  

^a Service de Pathologie Professionnelle et Environnement   (France)

^b Medgenix Diagnostics SA   (Belgium)

^c Hopital Dron   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY;

ANTIGENS, CD; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 0029891685     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01781095     Document Type: Article

References (22)

1. Fauci, A. S.: The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239 (1988) 617-622.
2. Matsuyama, T., Kobayashi, N., Yamamoto, N.: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5 (1991) 1405-1417.
3. Hober, D., Lucas, B., Wattré, P., Capron, A., Haque, A.: TNFα production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNFα is one of the mediators causing lysis of HIV-infected T4 cells. Clin. Immunol. Immunopathol. 62 (1992) 168-175.
4. Lahdevista, J., Maury, C. P. J., Teppo, A., Repo, H.: Elevated levels of circulating cachectin tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85 (1988) 289-291.
5. Hober, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., Capron, A.: Production of tumor necrosis factor (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78 (1989) 329-333.
6. Roux-Lombard, P., Modoux, C., Cruchaud, A., Dayer, J. M.: Purified blood monocytes from HIV 1 infected patients produce high levels of TNFα and IL-1. Clin. Immunol. Immunopathol. 50 (1989) 374-384.
7. Wright, S. C., Jewett, A., Mitsuyasu, R., Bonavida, B.: Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 14 (1988) 99-104.
8. Reddy, M. M., Sorrell, S. J., Lange, M., Grieco, M. H.: Tumor necrosis factor and HIV p24 antigen levels in serum of HIV-infected populations. J. Acquir. Immune Defic. Syndr. 1 (1988) 436-440.
9. Kalinkovich, A., Engelmann, H., Harpaz, N., Burstein, R., Barak, V., Kalickman, I., Wallach, D., Bentwich, Z.: Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin. Exp. Immunol. 89 (1992) 351-355.
10. Godfried, M. H., van der Poll, T., Jansen, J., Romijin, J. A., Eeftinck Schattenkerk, J. K. M., Endert, E., van Deventer, S. J. H., Sauerwein, H. P.: Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7 (1993) 33-36.
11. Aukrust, P., Liabakk, N. B., Muller, F., Lien, E., Espevik, T., Frøland, S.: Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologie parameters. J. Infect. Dis. 169 (420-424).
12. Zangerle, R., Gallati, H., Sarcletti, M., Weiss, G., Denz, H., Wachter, H., Fuchs, D.: Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J. Acquir. Immune Defic. Syndr. 7 (1994) 79-85.
13. Godfried, M. H., van der Poll, T., Weverling, G. J., Mulder, J. W., Jansen, J., van Deventer, S. J. H., Sauerwein, H. P.: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 169 (1994) 739-745.
14. Aukrust, P., Liabakk, N.-B., Müller, F., Espevik, T., Frøland. S. S.: Activation of tumor necrosis factor-α system in HIV-1 infection: association with markers of immune activation. Infection 23 (1995) 9-15.
15. Centers for Diseases Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (1992) 1-19.
16. Fahey, J. L., Taylor, J. M. G., Detels, R., Hofman, B., Melmed, R., Nishanian, P., Giorgi, J. V.: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322 (1990) 166-172.
17. Lantz, M., Malik, S., Slevin, M. L., Olsson, I.: Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2 (1990) 406.
18. Scott-Alagara, S.D., Vuillier, F., Marasescu, M., De Saint Martin, J., Dignero, G.: Serum levels of II-2, II-1 and TNFα and soluble receptor of II-2 in HIV-1 infected patients. AIDS Res. and Hum. Retrovirus. 7 (1991) 381-386.
19. Jones, P. D., Shelley, L., Wakefield, D.: Tumor necrosis factor-α in advanced HIV infection in the absence of AIDS-related secondary infections. J. Acquir. Immune Defic. Syndr. 5 (1992) 1266-1271.
20. Hober, D., Ajana, F., Petit, M. C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., Wattré, P., Maniez-Montreuil, M.: Granulocyte-macrophage colony stimulating factor and tumor necrosis factor α in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37 (1993) 785-792.
21. Aderka, D., Engelmann, H., Shemer-Avni, Y., Hornik, V., Galil, A., Sarov, B., Wallach, D.: Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res. 11 (1992) 157-159.
22. Rimaniol, A.-C., Boussin, F., Herbelin, A., De Groote, D., Dormont, D., Bach, J.-F., Descamps-Latscha, B., Zavala, F.: Induction of soluble tumor necrosis factor receptor (sTNF-Rp75) release by HIV adsorption on cultured human monocytes. Eur. J. Immunol. 24 (1994) 2055-2060.